Animal model for cholesteatoma induced in the gerbil: Will the profiles of differentiation/growth-regulatory markers be similar to the clinical situation?

Laryngoscope

Volumn 117, Issue 4, 2007, Pages 706-711

  Choufani, Georges ^a   Roper, Nicolas ^a   Delbrouck, Carine ^a   Hassid, Sergio ^a   Gabius, Hans Joachim ^b  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Animal model; Cholesteatoma; Galectins; Macrophage migration inhibitory factor; Retinoic acid receptors

Indexed keywords

BIOLOGICAL MARKER; GALECTIN 1; GALECTIN 3; GALECTIN 7; GALECTIN 8; MACROPHAGE MIGRATION INHIBITION FACTOR; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CHOLESTEATOMA; COMPARATIVE STUDY; COMPUTER ANALYSIS; CONTROLLED STUDY; DISEASE MODEL; EXPERIMENTAL MODEL; EXTERNAL AUDITORY CANAL; FEMALE; GERBIL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LABELING INDEX; MACROPHAGE MIGRATION; MICROSCOPY; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; VALIDITY;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL DIFFERENTIATION; CHOLESTEATOMA; DISEASE MODELS, ANIMAL; FEMALE; GALECTINS; GERBILLINAE; IMMUNOHISTOCHEMISTRY; MACROPHAGE MIGRATION-INHIBITORY FACTORS; RECEPTORS, RETINOIC ACID;

EID: 34147103314     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/mlg.0b013e318031d09d     Document Type: Article

References (21)

1. Miyazaki H, Kojima H, Tanaka Y, et al. Terminal differentiation of epithelial cells in middle ear cholesteatoma: investigation of patterns of expression of protein kinase C-delta and protein kinase C-eta. Laryngoscope 1999;109:1785-1792.
2. Kim TT, Chen CT, Huang CC. Expression of annexin II in human middle ear cholesteatoma. Otolaryngol Head Neck Surg 1998;118:324-328.
3. Bayazit YA, Karakok M, Ucak R, Kanlikama M. Cycline-dependant kinase inhibitor, p27 (KIP 1), is associated with cholesteatoma. Laryngoscope 2001;111:1037-1041.
4. Akimoto R, Pawankar R, Yagi T, Baba S. Acquired and congenital cholesteatoma: determination of tumour necrosis factor-α, intercellular adhesion molecule-1, interleukin 1α and lymphocyte functional antigen-1 in the inflammatory process. ORL J Otorhinolaryngol Relat Spec 2000;62:257-265.
5. Choufani G, Mahillon V, Decaestecker C, et al. Determination of the levels of expression of sarcolectin and calcyclin and of the percentages of apoptotic but not proliferating cells to enable distinction between recurrent and non-recurrent cholesteatomas. Laryngoscope 1999;109:1825-1831.
6. Gabius HJ. Glycohistochemistry: the why and how of detection and localization of endogenous lectins. Anat Histol Embryol 2001;30:3-31.
7. Gabius HJ, Siebert HC, André S, et al. Chemical biology of the sugar code. Chem Biochem 2004;5:740-764.
8. Sheikholeslam-Zadeh R, Decaestecker C, Delbrouck C, et al. The levels of expression of galectin-3, but not of galectins-1 and galectins-8, correlate with apoptosis in human cholesteatomas. Laryngoscope 2001;111:1042-1047.
9. Simon P, Decaestecker C, Choufani G, et al. The levels of retinoid RAR-α receptors correlate with galectin-1, -3 and -8 expression in human cholesteatomas. Hear Res 2001;156:1-9.
10. Choufani G, Ghanooni R, Decaestecker C, et al. Detection of macrophage migration inhibitory factor (MIF) on human cholesteatomas and functional implications of correlations to recurrence status and to expression of matrix metalloproteinase-3/9, retinoic acid receptor-β, and anti-apoptotic galectins-3. Laryngoscope 2001;22:1656-1662.
11. Schmidt SH, Hellstrom S. Experimental cholesteatoma in the rat. Acta Otolaryngol 1994;114:430-434.
12. McGinn MD, Chole RA, Henry KR. Cholesteatoma: experimental induction in the Mongolian gerbil, meriones unguiculatus. Acta Otolaryngol 1982;61-93.
13. Gabius HJ. Influence of type of linkage and spacer on the interaction of betagalactoside-binding proteins with immobilized affinity ligands. Anal Biochem 1990;189:91-94.
14. Siebert HC, Adar R, Arango R, et al. Involvement of laser photo-CIDNP (chemically induced dynamic nuclear polarization)-reactive amino acid side chains in ligand binding by galactoside-specific lectins in solution. Eur J Biochem 1997;249:27-38.
15. Agrwal N, Sun Q, Wang SY, Wang JL. Carbohydrate-binding protein 35. I. Properties of the recombinant polypeptide and the individuality of the domains. J Biol Chem 1993;268:14932-14939.
16. Bardosi A, Dimitri T, Wosgien B, Gabius HJ. Expression of endogenous receptors for neoglycoproteins, especially lectins, that allow fiber typing on formaldehyde-fixed, paraffin-embedded muscle biopsy specimens. A glycohistochemical, immunohistochemical, and glycobiochemical study. J Histochem Cytochem 1989;37:989-998.
17. Kopitz J, von Reitzenstein C, Burchert M, Cantz M, Gabius HJ. Galectin-1 is a major receptor for ganglioside GM1, a product of the growth-controlling activity of a cell surface ganglioside sialidase, on human neuroblastoma cells in culture. J Biol Chem 1998;273:11205-11211.
18. Gabius HJ, Engelhardt R, Rehm S, Barondes SH, Cramer F. Presence and relative distribution of three endogenous beta-galactoside-specific lectins in different tumour types of rat. Cancer J 1986;1:19-22.
19. Hadari YR, Paz K, Dekel R, Mestrovic T, Accili D, Zick Y. Galectin-8. A new rat lectin, related to galectin-4. J Biol Chem 1995;270:3447-3453.
20. Rosengren E, Bucala R, Aman P, et al. The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol Med 1996;2:143-149.
21. Lefranc F, Chevalier C, Vinchon M, et al. Characterization of the levels of expression of retinoic acid receptors (RARα, RARβ, RARγ), galectin-3, macrophage migration inhibitory factor (MIF) and p53 in a series of 51 adamantinomatous craniopharyngiomas. J Neurosurg 2003;98:145-153.